On the morning of September 26th, the Technology Department of Biocompounds Pharmaceutical Inc. held a special brainstorming session to address core technical challenges of the project through in-depth technical exchange.

During the discussion, the key mechanisms and technical nodes of the project's reaction mechanism were clearly outlined on a whiteboard. Liu Bin, Executive Vice President of Biocompounds Pharmaceutical and General Manager of Peak North Carolina, analyzed the core mechanism, proposing potential optimization directions based on cutting-edge industry technologies and the project's actual needs, thus anchoring the core focus of the discussion. Members of the Technology Department engaged in discussions, raising questions and considerations from multiple dimensions, including reaction kinetics and condition control. They deduced the difficulties and bottlenecks in the reaction layer by layer, deepening their understanding of the technical logic through the clash of ideas, and gradually clarifying a clearer technical path.

A representative from Biocompounds Pharmaceutical stated that this discussion model, anchored by key technologies, involving deep participation from all members, and facilitating multi-dimensional brainstorming, will be promoted and applied within the department as an example. In the future, the Biocompounds Pharmaceutical Technology Department plans to conduct such discussions regularly, using more specialized topics as a platform, to continuously activate the team's innovative vitality.